Pennell Benjamin T, Murphy Claire V, Byrd Cindy, Tubbs Crystal
Department of Pharmacy (Drs Pennell, Murphy, and Tubbs) and APRN Critical Care, Trauma, and Burn (Dr Byrd), The Ohio State University Wexner Medical Center, Columbus.
Crit Care Nurs Q. 2017 Oct/Dec;40(4):414-423. doi: 10.1097/CNQ.0000000000000177.
Health care costs are rising in the United States with a significant amount of this spend attributed to pharmaceutical costs. The reasons for rising pharmaceutical costs are multifactorial and may include the increase in single source manufacturers of generic medications, drug shortages, the Food and Drug Administration's unapproved drug approval initiative, and generic rebranding. Many of these factors impact the intensive care unit directly creating the need to implement cost-savings strategies to ensure the financial health of an organization and reduce the financial burden for patients. To mitigate rising costs, we have outlined a number of both operational and clinical cost-savings measures derived from the literature and from institutional experience. Engaging the multidisciplinary team in the development and implementation of these initiatives will ensure their success and will maximize their impact.
美国的医疗保健成本正在上升，其中很大一部分支出归因于药品成本。药品成本上升的原因是多方面的，可能包括仿制药单一来源制造商的增加、药品短缺、美国食品药品监督管理局的 Unapproved Drug Approval Initiative（未经批准药物批准计划）以及仿制药重新品牌化。这些因素中的许多直接影响重症监护病房，因此需要实施成本节约策略，以确保机构的财务健康并减轻患者的经济负担。为了缓解成本上升的问题，我们概述了一些从文献和机构经验中得出的运营和临床成本节约措施。让多学科团队参与这些举措的制定和实施将确保其成功，并将使其影响最大化。
